1 / 1

nrclinonc.2010.37-pf1

Figure 1 Comparison of a | PFS and b | overall survival curves from the JGOG study on dosedense therapy 1 and the GOG study on IP therapy. Thomas Hogberg (2010) Current drugs still have potential in advanced ovarian cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.37.

walt
Download Presentation

nrclinonc.2010.37-pf1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Figure 1 Comparison of a | PFS and b | overall survival curves from the JGOG study on dosedense therapy1 and the GOG study on IP therapy Thomas Hogberg(2010)Current drugs still have potential in advanced ovarian cancerNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.37

More Related